The Growing Requirements for Minimally Invasive Procedures Drives the Nitinol Medical Devices Market

The Growing Requirements for Minimally Invasive Procedures Drives the Nitinol Medical Devices Market

Nitinol medical devices such as guidewires, medical guidewires, vascular stents, etc. are used in minimally invasive surgeries to support or replace anatomical structures within the body. With superior biocompatibility and unique temperature-dependent properties, nitinol helps design medical products that can be compressed for smaller size introducers during surgery and self-expand to the original shape inside the body.

The global Nitinol Medical Devices Market is estimated to be valued at US$ 18.43 Billion in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
One of the key trends in the nitinol medical devices market is the development of advanced functionalities. Manufacturers are focusing on developing nitinol alloys blended with other materials like platinum, copper, etc. to impart reinforced mechanical properties. This helps design medical implants and tools with improved fatigue resistance, corrosion resistance and shape memory effect. For instance, nitinol alloys blended with platinum exhibit greater shape memory compared to unblended nitinol. R&D activities are also underway to enhance the biocompatibility and hemocompatibility of nitinol for its extensive usage in minimally invasive surgeries. The advent of 3D printing technology has further expanded application areas of nitinol in the medical field by facilitating precision manufacturing of complex nitinol devices.

Porter's Analysis

Threat of new entrants: Low. High capital requirements and stringent regulatory environment poses barrier for new entrants.

Bargaining power of buyers: Moderate. Large number of established players limits options for buyers.

Bargaining power of suppliers: Moderate. Suppliers have influence due to specialized production process but established relationships balance negotiation power.

Threat of new substitutes: Low. Nitinol has unique properties that are difficult to substitute.

Competitive rivalry: High. Players compete on product innovation, quality and geographic expansion.

Key Takeaways

The Global Nitinol Medical Devices Market Size is expected to witness high growth. The global Nitinol Medical Devices Market is estimated to be valued at US$ 18.43 Billion in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030.

Regional analysis related content comprises growing medical applications and increasing healthcare spending in North America and Asia Pacific will drive the market.

Key players operating in the Nitinol Medical Devices market are Abbott, Boston Scientific Corporation, Cook Group, Terumo Corporation and Micro-Tech. Abbott launched a new renal stent in the European market in 2021. Boston Scientific received FDA clearance for its Complete SE architecture drug-eluting stent in early 2022.

For more Insights, Read –

https://www.marketwebjournal.com/nitinol-medical-devices-market-trends-size-and-share-analysis/

Check more trending articles related to this topic:

https://careersplay.com/the-rising-trend-of-biohacking-and-its-opportunities